Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.11M | ﹤0.01% |
881,123
+16,948
| +2% | +$36.4K |
|
|
SRG
2577
Seritage Growth Properties
SRG
$137M
| $2.11M | ﹤0.01% |
218,906
+14,276
| +7% | +$134K |
|
2578
KRONOS Worldwide
KRO
$708M
| $2.11M | ﹤0.01% |
178,824
+10,450
| +6% | +$101K |
|
2579
Kyverna Therapeutics
KYTX
$457M
| $2.11M | ﹤0.01% |
+84,880
| New | +$2.37M |
|
2580
Autohome
ATHM
$2.68B
| $2.11M | ﹤0.01% |
80,388
| – | – |
|
2581
iShares Core US REIT ETF
USRT
$4.66B
| $2.09M | ﹤0.01% |
38,898
-2,363
| -6% | -$125K |
|
2582
Prime Medicine
PRME
$508M
| $2.08M | ﹤0.01% |
297,823
+1,635
| +0.6% | +$12.4K |
|
2583
Grindr
GRND
$3.18B
| $2.07M | ﹤0.01% |
204,205
-8
| -0% | -$71 |
|
2584
EyePoint Inc
EYPT
$1.04B
| $2.06M | ﹤0.01% |
99,850
+21,440
| +27% | +$531K |
|
2585
Hippo Holdings
HIPO
$859M
| $2.06M | ﹤0.01% |
112,855
+2,350
| +2% | +$28.9K |
|
2586
NewtekOne
NEWT
$431M
| $2.06M | ﹤0.01% |
187,312
+3,610
| +2% | +$42.5K |
|
|
ONTF
2587
DELISTED
ON24
ONTF
| $2.04M | ﹤0.01% |
285,302
-2,509
| -0.9% | -$18.2K |
|
2588
El Pollo Loco
LOCO
$504M
| $2.03M | ﹤0.01% |
208,758
+1,083
| +0.5% | +$9.75K |
|
2589
Forrester Research
FORR
$221M
| $2.03M | ﹤0.01% |
94,024
+1,466
| +2% | +$33.3K |
|
2590
ORIX
IX
$43.7B
| $2.02M | ﹤0.01% |
91,855
+21,525
| +31% | +$438K |
|
2591
IMAX
IMAX
$2.8B
| $2.02M | ﹤0.01% |
124,674
-32,706
| -21% | -$497K |
|
2592
Universal Logistics Holdings
ULH
$480M
| $2.01M | ﹤0.01% |
54,483
+2,440
| +5% | +$78.6K |
|
2593
Absci
ABSI
$1.34B
| $2M | ﹤0.01% |
351,403
-5,605
| -2% | -$25.3K |
|
2594
Solid Power
SLDP
$479M
| $1.97M | ﹤0.01% |
970,379
-26,384
| -3% | -$40.2K |
|
2595
Liquidia Corp
LQDA
$7.46B
| $1.96M | ﹤0.01% |
133,044
+1,280
| +1% | +$17.8K |
|
2596
HBT Financial
HBT
$1.3B
| $1.96M | ﹤0.01% |
103,048
+1,080
| +1% | +$21K |
|
2597
Bank of Marin Bancorp
BMRC
$474M
| $1.96M | ﹤0.01% |
116,987
+2,115
| +2% | +$38.7K |
|
2598
Futu Holdings
FUTU
$15B
| $1.94M | ﹤0.01% |
35,750
+1,084
| +3% | +$55.9K |
|
2599
Comtech Telecommunications
CMTL
$49.7M
| $1.92M | ﹤0.01% |
560,745
+38,238
| +7% | +$240K |
|
2600
Vroom Inc
VRM
$37.2M
| $1.91M | ﹤0.01% |
142,489
+56,884
| +66% | +$1.15M |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.